The forecasted average length of stay for malignant neoplasm of the uterus in Canadian hospitals remains stable from 2024 to 2026 at 3.7 days, with a slight decrease to 3.6 days from 2027 onwards. The actual data for 2023 was not provided, so direct comparisons or percentage variations year-on-year from 2023 cannot be assessed.
Future trends to watch for include advancements in minimally invasive surgical techniques and enhanced recovery protocols, which could further reduce hospital stay durations. Additionally, growth in outpatient cancer care and improved early detection initiatives might affect future hospitalization needs and durations.
